The dosimetric impact of heterogeneity corrections in high-dose-rate ¹⁹²Ir brachytherapy for cervical cancer: Investigation of both conventional Point-A and volume-optimized plans

Hyer DE, Sheybani A, Jacobson GM, Kim Y. The dosimetric impact of heterogeneity corrections in high-dose-rate (1)(9)(2)Ir brachytherapy for cervical cancer: Investigation of both conventional Point-A and volume-optimized plans. Brachytherapy 2012;11:515-20

Tony Roslund

Tony Roslund, 421 West Riverside Avenue, Suite 105, Spokane, WA, 99201